What is Ménière’s Disease and how is it treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ménière's Disease and Its Treatment

Ménière's disease is an inner ear disorder characterized by episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness, with no cure but multiple treatment options ranging from dietary modifications to surgical interventions. 1, 2

Definition and Diagnostic Criteria

Ménière's disease is defined by the following criteria:

  • Two or more spontaneous attacks of vertigo, each lasting 20 minutes to 12 hours
  • Audiometrically documented fluctuating low- to mid-frequency sensorineural hearing loss in the affected ear on at least one occasion before, during, or after a vertigo episode
  • Fluctuating aural symptoms (hearing loss, tinnitus, or fullness) in the affected ear 1

The underlying pathology is endolymphatic hydrops, an excessive accumulation of endolymph fluid in the inner ear 2, 3.

Clinical Presentation

Cardinal Symptoms

  • Vertigo: Rotational sensation of self-motion or environment motion lasting 20 minutes to 12 hours
  • Hearing loss: Fluctuating, initially affecting low to mid-frequencies
  • Tinnitus: Ringing, buzzing, or other noises that may fluctuate in intensity
  • Aural fullness: Sensation of pressure or plugging in the affected ear 1, 2

Additional Features

  • Typically affects adults in their 40s-70s
  • Can be unilateral or bilateral (25-40% of cases)
  • May include drop attacks (Tumarkin's Otolithic Crisis) in later stages
  • Symptoms are episodic and unpredictable 1, 2, 4

Differential Diagnosis

Condition Distinguishing Features
Vestibular migraine Attacks may be shorter or longer; less likely to have hearing loss; often has migraine history; photophobia common
BPPV Brief vertigo (seconds) triggered by position changes; no hearing loss
Vestibular neuritis Prolonged vertigo (days); no hearing loss
Labyrinthitis Prolonged vertigo with sudden non-fluctuating hearing loss
Vestibular schwannoma Chronic imbalance rather than episodic vertigo; progressive non-fluctuating hearing loss
Stroke/ischemia May have other neurological symptoms; usually no associated hearing loss [1,2]

Diagnostic Workup

  1. Detailed history: Focus on vertigo characteristics, duration, associated symptoms
  2. Audiometric testing: Document fluctuating low- to mid-frequency sensorineural hearing loss
  3. Video/electronystagmography: Evaluate vestibular function
  4. Electrocochleography: Measure electrical responses of cochlea and auditory nerve
  5. MRI of brain: Rule out other causes and potentially visualize endolymphatic hydrops 1

Treatment Approach

First-Line: Lifestyle and Dietary Modifications

  • Low-sodium diet (1500-2300 mg daily)
  • Limit alcohol consumption
  • Limit caffeine intake
  • Identify and manage triggers (stress, allergies, etc.) 1, 2

Second-Line: Medications

  • Diuretics: To reduce fluid volume
  • Betahistine: Histamine analog that increases inner ear blood flow
  • Antivertigo medications: For acute vertigo symptoms
  • Antihistamines: If allergies are a contributing factor 1, 2, 4

Third-Line: Noninvasive Therapies

  • Vestibular rehabilitation: Physical therapy to improve balance
  • Hearing aids: For hearing loss management 1, 2

Fourth-Line: Middle Ear Injections

  • Intratympanic steroids: Anti-inflammatory effect
  • Intratympanic gentamicin: Chemical labyrinthectomy (can affect hearing) 1, 2, 4

Fifth-Line: Surgical Options

  • Endolymphatic sac decompression: Hearing-sparing procedure
  • Vestibular nerve section: Hearing-sparing procedure
  • Labyrinthectomy: Ablative procedure (sacrifices remaining hearing) 1, 2

Important Considerations

Patient Education

  • Explain the chronic, fluctuating nature of the disease
  • Encourage symptom journaling to identify triggers
  • Discuss quality of life impact and psychological effects 1, 2

Monitoring

  • Regular audiometric testing to track hearing loss progression
  • Document changes in vertigo frequency and severity
  • Assess impact on quality of life 1, 2

Bilateral Disease Caution

  • Consider bilateral potential (25-40% of cases) before destructive procedures
  • Ablative procedures like labyrinthectomy should be approached with caution as they sacrifice remaining hearing 1, 4

Prognosis

  • Disease course can be progressive or non-progressive
  • Vertigo attacks may decrease over time, but hearing loss often progresses
  • Quality of life can be significantly impacted by unpredictable attacks, causing anxiety, depression, and social isolation 1, 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Meniere's Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Meniere's disease.

Nature reviews. Disease primers, 2016

Research

Menière's disease.

Handbook of clinical neurology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.